Galmed Pharmaceuticals (GLMD) Return on Invested Capital (2016 - 2018)

Galmed Pharmaceuticals' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.02% for Q4 2018.

• In Q4 2018, Return on Invested Capital changed N/A year-over-year to 0.02%; the TTM figure through Dec 2018 stood at 0.02% (changed N/A YoY), while the FY2024 annual figure was 0.04%, changed N/A from the prior year.
• Return on Invested Capital for Q4 2018 stood at 0.02%, down from 0.02% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.19% in Q4 2016, with the low at 0.02% in Q4 2018.
• The 3-year median for Return on Invested Capital is 0.15% (2017), against an average of 0.11%.
• The sharpest annual moves came in 2017 and 2018: Return on Invested Capital decreased 1 bps in 2017, then declined 11 bps in 2018.
• Galmed Pharmaceuticals' Return on Invested Capital stood at 0.19% in 2016, then declined by 19 bps to 0.15% in 2017, then sank by 85 bps to 0.02% in 2018.
• Business Quant data shows GLMD's Return on Invested Capital at 0.02% in Q4 2018, 0.02% in Q3 2018, and 0.04% in Q2 2018.